lung cancer
Combination therapy shows promising results for treatment of advanced ovarian and lung cancer
A combination of drugs has offered promising results in an early clinical trial, where it has shrunk tumours in ovarian and lung cancer patients and prevented tumour growth for nearly six months. Read more
Currently available cancer treatment useful in treatment of adenocarcinoma, say researchers
A cancer treatment that is already approved and being used for certain types of cancer has been found to block cell growth in a common form of lung cancer, for which there is no specific treatment currently available. Read more
Lung cancer drug now available on NHS thanks to new deal
Opdivo, also known as nivolumab, will now be available to NHS patients suffering from lung cancer as the drug’s manufacturer, Bristol-Myers Squibb, offers the National Institute for Health and Care Excellence (NICE) a new cancer drugs fund (CDF) deal Read more
'Encouraging' lung cancer drug approved on NHS
A drug that can lead to the reduction in lung cancer tumours has been made available on the NHS. Read more
Award helps lung cancer candidate enter the clinic
An award to progress a lung cancer candidate into the clinic has been given to Queen’s University Belfast and Domainex Read more
70 clinical centres selected for lung cancer drug trial
OSE Pharma has selected 70 international clinical centres to participate in its pivotal phase three clinical trial of Tedopi for patients diagnosed with advanced non-small cell lung cancer (NSCLC) Read more
